Biomerica Unveils Cancer-Ulcer Test
Dow Jones
Biomerica Inc. said it has developed a test that helps detect and monitor the presence of peptic ulcers and stomach cancer.
The Newport Beach medical technology company said the test measures the amounts of Pepsinogen-1 present in human serum, which can mark the presence of a peptic ulcer. The test can also be used to measure the effectiveness of treatments.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
